Screener
AnaptysBio, Inc. ANAB EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | (52,884) | (39,329) |
| Other comprehensive loss: | ||
| Unrealized loss on available-for-sale securities | (122) | (144) |
| Comprehensive loss | $(53,006) | $(39,473) |
| Net loss per common share: | ||
| Basic and diluted | $(1.84) | $(1.28) |
| Weighted-average number of shares outstanding: | ||
| Basic and diluted | 28,691 | 30,644 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s EPS (basic)?
- AnaptysBio, Inc. (ANAB) reported EPS (basic) of -$1.84 in Q1 2026.
- How has AnaptysBio, Inc.'s EPS (basic) changed year-over-year?
- AnaptysBio, Inc.'s EPS (basic) decreased by 43.8% year-over-year, from -$1.28 to -$1.84.
- What is the long-term trend for AnaptysBio, Inc.'s EPS (basic)?
- Over 3 years (2021 to 2024), AnaptysBio, Inc.'s EPS (basic) has grown at a 34.6% compound annual growth rate (CAGR), from -$2.11 to -$5.15.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about AnaptysBio, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude